Cure Breast Cancer… with Venom?! (1 Hour)
Triple-negative, HER2 positive breast cancers are especially aggressive and have limited treatment options.
This type of cancer is more likely to have already spread by the time it’s found. And it’s also more likely to return after treatment.
That’s why researchers are leaving no stone unturned in the search for a cure for this nasty disease.
And just recently, Australian researchers identified a natural substance that can KILL these aggressive breast cancer cells… and it comes from a most unlikely source:
Venom.
This isn’t venom from a poisonous snake or a scorpion or spider. Or even from a nasty hornet or yellow jacket.
Instead, it’s from the typically docile honey bee.
Honey bees aren’t as likely to sting you as other bees, but that doesn’t mean they can’t.
And it turns out their venom could be the key to stopping aggressive triple-negative breast cancers.
In a study published in Nature Precision Oncology, researchers tested the active chemical from venom known as melittin from honey bees found in Australia, Ireland, and England.
This is the chemical responsible for causing the “sting” in a bee sting.
They found that the bee venom could shut down cancer cells while leaving healthy cells relatively untouched.
Once researchers determined its effectiveness in a dish, they tested the venom on mice and the chemotherapy drug docetaxel.
The mice receiving both treatments had smaller tumors than the untreated mice.
It seems that the bee venom greatly reduced the amount of chemical messages the cancer cells can send within just 20 minutes… and DESTROYED the cancer cell membrane in just 60 minutes.
This confirms other studies showing that melittin can prohibit the growth of other types of cancer, including melanoma, lung cancer, leukemia, and ovarian cancer.
Melittin can be made synthetically, and seems to have the same anti-cancer effects of the real thing.
Of course, research is still in the early stages, and we need to find out more—like the safest and most efficient concentrations of the venom—but it’s a promising start.